Fampridine Rowa 10 mg prolonged-release tablets

Licence status
Authorised: 01/07/2022
Active substances
Fampridine
Dosage Form
Prolonged-release tablet
Licence number
PA0074/087/001
Licence holder
Rowa Pharmaceuticals Limited

Product documents

Licence information

ATC code
N07XX07 fampridine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (Summary of Product Characteristics, section 4.2).
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
01/07/2022